» Journals » J Pediatr Endocrinol Metab

Journal of Pediatric Endocrinology & Metabolism : Jpem

The Journal of Pediatric Endocrinology & Metabolism (JPEM) is a leading scientific journal that focuses on the study of endocrine disorders in children. It publishes high-quality research articles, reviews, and case reports related to pediatric endocrinology and metabolism. JPEM serves as a valuable resource for healthcare professionals, researchers, and educators in the field, providing up-to-date information on the latest advancements and developments in pediatric endocrinology and metabolism.

Details
Abbr. J Pediatr Endocrinol Metab
Start 1995
End Continuing
Frequency Monthly, 2004-
p-ISSN 0334-018X
e-ISSN 2191-0251
Country Germany
Language English
Metrics
h-index / Ranks: 4869 73
SJR / Ranks: 9547 456
CiteScore / Ranks: 9809 2.40
JIF / Ranks: 6261 1.4
Recent Articles
1.
Kodytkova A, Amaratunga S, El-Lababidi E, cermakova I, cerna J, Dvorakova M, et al.
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40080424
Objectives: Subsequent to early life feeding issues, children with Prader-Willi syndrome (PWS) develop hyperphagia and severe obesity. Growth hormone (GH) therapy has been approved in PWS to improve growth, body...
2.
Sodero G, Cipolla C, Rigante D, Arzilli F, Mercuri E
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40068954
Objectives: We conducted a scoping review and analyzed the medical literature on PubMed to assess any potential short-term and long-term benefits of pubertal induction in patients with DMD. Content: We...
3.
Xie D, Guo S, Ma H, Li Y, Zheng R, Zhang J, et al.
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40068940
Objectives: Familial Male-Limited Precocious Puberty (FMPP) is a rare autosomal-dominant genetic condition with sexual dimorphism. We aim to summarize the clinical characteristics of FMPP patients and emphasize the use of...
4.
Cay M, Turan I, Mengen E, Cimen A, Celebi S, Yuksel B
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40056055
Objectives: The objective of this study is to determine the optimal interval between repeat thyroid fine-needle aspiration (FNA) biopsies in children and adolescents and to evaluate whether this has any...
5.
Kumru Akin B, Goksoy E
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40056050
Objectives: The primary goal in managing glycogen storage disorders (GSD) is to implement dietary therapy through regular glucose monitoring while attempting to prevent complications. Self-monitoring of blood glucose is often...
6.
Krnic N, Braovac D, Vinkovic M, Petrinovic Doresic J, Dumic Kubat K
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40055929
Objectives: To present a patient diagnosed with single, large-scale mitochondrial DNA (mtDNA) deletion (SLSMD), a rare and progressive multisystem disorder. Diverse initial symptoms, evolving and overlapping phenotypes, along with genetic...
7.
Devulapalli C
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40025874
Objectives: This review explores the relationship between physical activity and serum 25-hydroxyvitamin D (25(OH)D) levels in children and adolescents, highlighting the importance of vitamin D for bone health and muscle...
8.
Anastasovska V, Kocova M, Zdraveska N, Tesovnik T, Debeljak M, Kovac J
J Pediatr Endocrinol Metab . 2025 Mar; PMID: 40023771
Objectives: Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is an autosomal recessive disorder of fatty acid oxidation, with potentialy fatal outcome. Early diagnosis of MCADD by acylcarnitine analysis on newborn screening using...
9.
Arora S, Banerjee S, George A, Bala A, Thingnam S, Rohit M, et al.
J Pediatr Endocrinol Metab . 2025 Mar; 38(3):305-309. PMID: 40022592
Objectives: Homozygous familial hypercholesterolemia (HoFH) is a rare inherited disorder of lipoprotein metabolism associated with significant morbidity and early mortality. The conventional management with lipid-lowering drugs and lipoprotein apheresis is...
10.
Kose E, Ozcay F, Aydin H, Kasapkara C, Inci A, Kucukcongar Yavas A, et al.
J Pediatr Endocrinol Metab . 2025 Feb; PMID: 40009407
Objectives: Empagliflozin has been used for the treatment of over 100 glycogen storage disease type Ib (GSDIb) patients worldwide since 2019. We aimed to evaluate the effect of empagliflozin treatment...